John Irvin Garrett
Engineers at Stover, Fort Collins, CO
License number
Colorado 29091
Issued Date
Jun 30, 1993
Renew Date
Jul 1, 1997
Expiration Date
Jul 1, 1997
Type
Professional Engineer
Address
Address
2014 Stover St, Fort Collins, CO 80525
Professional information
John Garrett - Windsor, CO
Work:
Facilities Management Advisors LLC
President & CEO Able Services/Engineering - San Francisco, CA
Executive Vice President SBM Management - McClellan, CA
Senior Vice President & Chief Business Development Officer
President & CEO Able Services/Engineering - San Francisco, CA
Executive Vice President SBM Management - McClellan, CA
Senior Vice President & Chief Business Development Officer
Education:
Regis University - Denver, CO
MBA in Strategic Management Oregon State University - Corvallis, OR
BS in Physiology
MBA in Strategic Management Oregon State University - Corvallis, OR
BS in Physiology
Skills:
Customer Relationship Management (CRM), Strategic Planning, Sales Management, New Business Development, Performance Management, Outsourcing, Technical Writing, Marketing Strategy, Sustainability, Financial Modeling
Polymeric Delivery Formulations Of Leuprolide With Improved Efficacy
US Patent:
6565874, May 20, 2003
Filed:
Nov 13, 2000
Appl. No.:
09/711758
Inventors:
Richard L. Dunn - Fort Collins CO
John Steven Garrett - Fort Collins CO
Harish Ravivarapu - Union City CA
Bhagya L Chandrashekar - Fort Collins CO
John Steven Garrett - Fort Collins CO
Harish Ravivarapu - Union City CA
Bhagya L Chandrashekar - Fort Collins CO
Assignee:
Atrix Laboratories - Fort Collins CO
International Classification:
A61F 200
US Classification:
424426, 424422, 424423, 424424, 5147723
Abstract:
The present invention is directed to a flowable composition that is suitable for use as a controlled release implant. The flowable composition includes a biodegradable thermoplastic polyester that is at least substantially insoluble in aqueous medium or body fluid. The flowable composition also includes a biocompatible polar aprotic solvent. The biocompatible polar aprotic solvent is miscible to dispersible in aqueous medium or body fluid. The flowable composition also includes leuprolide acetate.
Polymeric Delivery Formulations Of Leuprolide With Improved Efficacy
US Patent:
6773714, Aug 10, 2004
Filed:
Feb 24, 2003
Appl. No.:
10/373400
Inventors:
Richard L. Dunn - Fort Collins CO
John Steven Garrett - Fort Collins CO
Harish Ravivarapu - Union City CA
Bhagya L. Chandrashekar - Scarborough ME
John Steven Garrett - Fort Collins CO
Harish Ravivarapu - Union City CA
Bhagya L. Chandrashekar - Scarborough ME
Assignee:
Atrix Laboratories, Inc. - Fort Collins CO
International Classification:
A61K 900
US Classification:
424426, 424422, 424423, 424424, 5147723
Abstract:
The present invention is directed to a flowable composition that is suitable for use as a controlled release implant. The flowable composition includes a biodegradable thermoplastic polyester that is at least substantially insoluble in aqueous medium or body fluid. The flowable composition also includes a biocompatible polar aprotic solvent. The biocompatible polar aprotic solvent is miscible to dispersible in aqueous medium or body fluid. The flowable composition also includes leuprolide acetate.
Polymeric Delivery Formulations Of Leuprolide With Improved Efficacy
US Patent:
2010023, Sep 16, 2010
Filed:
May 20, 2010
Appl. No.:
12/784343
Inventors:
Richard L. Dunn - Fort Collins CO, US
John Steven Garrett - Fort Collins CO, US
Harish Ravivarapu - Union City CA, US
Bhagya L. Chandrashekar - Fort Collins CO, US
John Steven Garrett - Fort Collins CO, US
Harish Ravivarapu - Union City CA, US
Bhagya L. Chandrashekar - Fort Collins CO, US
Assignee:
QLT USA, INC. - Willmington DE
International Classification:
A61K 38/08, A61P 5/24
US Classification:
514 15
Abstract:
The present invention is directed to a flowable composition that is suitable for use as a controlled release implant. The flowable composition includes a biodegradable thermoplastic polyester that is at least substantially insoluble in aqueous medium or body fluid. The flowable composition also includes a biocompatible polar aprotic solvent. The biocompatible polar aprotic solvent is miscible to dispersible in aqueous medium or body fluid. The flowable composition also includes leuprolide acetate.
Dapsone To Treat Rosacea
US Patent:
2014005, Feb 20, 2014
Filed:
Oct 25, 2013
Appl. No.:
14/063841
Inventors:
John S. Garrett - Fort Collins CO, US
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A61K 31/145, A61K 31/4164
US Classification:
424 59, 514646, 514386
Abstract:
The methods described herein provide treatment of rosacea using topical formulations of dapsone. The methods also provide treatment of rosacea with topical dapsone in combination with other active agents, including metronidazole. The methods avoid negative hematologic side effects, including hemolysis and hemolytic anemia, that are associated with oral administration of dapsone.
Polymeric Delivery Formulations Of Leuprolide With Improved Efficacy
US Patent:
8486455, Jul 16, 2013
Filed:
May 20, 2010
Appl. No.:
12/784304
Inventors:
Richard L. Dunn - Fort Collins CO, US
John Steven Garrett - Fort Collins CO, US
Harish Ravivarapu - Union City CA, US
Bhagya L. Chandrashekar - Fort Collins CO, US
John Steven Garrett - Fort Collins CO, US
Harish Ravivarapu - Union City CA, US
Bhagya L. Chandrashekar - Fort Collins CO, US
Assignee:
Tolmar Therapeutics, Inc. - Fort Collins CO
International Classification:
A61K 9/08
US Classification:
424484, 424422, 424400
Abstract:
The present invention is directed to a flowable composition that is suitable for use as a controlled release implant. The flowable composition includes a biodegradable thermoplastic polyester that is at least substantially insoluble in aqueous medium or body fluid. The flowable composition also includes a biocompatible polar aprotic solvent. The biocompatible polar aprotic solvent is miscible to dispersible in aqueous medium or body fluid. The flowable composition also includes leuprolide acetate.
Polymeric Delivery Formulations Of Leuprolide With Improved Efficacy
US Patent:
2004022, Nov 18, 2004
Filed:
Jun 21, 2004
Appl. No.:
10/872671
Inventors:
Richard Dunn - Fort Collins CO, US
John Garrett - Fort Collins CO, US
Harish Ravivarapu - Union City CA, US
Bhagya Chandrashekar - Scarborough ME, US
John Garrett - Fort Collins CO, US
Harish Ravivarapu - Union City CA, US
Bhagya Chandrashekar - Scarborough ME, US
Assignee:
Atrix Laboratories, Inc.
International Classification:
A61K031/445
US Classification:
514/317000
Abstract:
The present invention is directed to a flowable composition that is suitable for use as a controlled release implant. The flowable composition includes a biodegradable thermoplastic polyester that is at least substantially insoluble in aqueous medium or body fluid. The flowable composition also includes a biocompatible polar aprotic solvent. The biocompatible polar aprotic solvent is miscible to dispersible in aqueous medium or body fluid. The flowable composition also includes leuprolide acetate.
Dapsone To Treat Rosascea
US Patent:
8586010, Nov 19, 2013
Filed:
Feb 27, 2008
Appl. No.:
12/305413
Inventors:
John S. Garrett - Fort Collins CO, US
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A61K 8/00, A61K 8/18, A61Q 17/04, A61K 31/415, A61K 31/135
US Classification:
424 59, 514398, 514646
Abstract:
The methods described herein provide treatment of rosacea using topical formulations of dapsone. The methods also provide treatment of rosacea with topical dapsone in combination with other active agents, including metronidazole. The methods avoid negative hematologic side effects, including hemolysis and hemolytic anemia, that are associated with oral administration of dapsone.
Polymeric Delivery Formulations Of Leuprolide With Improved Efficacy
US Patent:
2007010, May 10, 2007
Filed:
Dec 21, 2006
Appl. No.:
11/643505
Inventors:
Richard Dunn - Fort Collins CO, US
John Garrett - Fort Collins CO, US
Harish Ravivarapu - Union City CA, US
Bhagya Chandrashekar - Scarborough ME, US
John Garrett - Fort Collins CO, US
Harish Ravivarapu - Union City CA, US
Bhagya Chandrashekar - Scarborough ME, US
International Classification:
A61K 38/09, A61F 2/02
US Classification:
424426000, 514015000
Abstract:
The present invention is directed to a flowable composition that is suitable for use as a controlled release implant. The flowable composition includes a biodegradable thermoplastic polyester that is at least substantially insoluble in aqueous medium or body fluid. The flowable composition also includes a biocompatible polar aprotic solvent. The biocompatible polar aprotic solvent is miscible to dispersible in aqueous medium or body fluid. The flowable composition also includes leuprolide acetate.